Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UI05MSP015CT in functional dyspepsia
NCT03225248Phase 3Completed
- Sponsor
- Korea United Pharm Inc.
- Start
- Nov 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of mosapride citrate sustained release in functional dyspepsia (FD), sponsored by Korea United Pharm Inc.. Started Nov 2014; status: completed.
02
Drugs
mosapride citrate sustained release
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT03225248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03225248.